[1] Knopman D. S.; Amieva H.; Petersen R. C.; Chételat G.; Holtzman D. M.; Hyman B. T.; Nixon R. A.; Jones, D. T. Alzheimer disease. Nat. Rev. Dis. Primers2021, 7, 33. [2] Christen, Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 2000, 71 (suppl.), 621S-629S. [3] Anand P.; Singh, B. A review on cholinesterase inhibitors for Alzheimer’s disease. Arch. Pharm. Res.2013, 36, 375-399. [4] Fillit H.; Green A. Aducanumab and the FDA — where are we now? Nat. Rev. Neurol.2021, 17, 129-130. [5] Scott L. E.; Orvig C. Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease. Chem. Rev.2009, 109, 4885-4910. [6] Cukierman, D. S; Accardo, E.; Gomes R. G.; De Falco, A.; Miotto, M. C.; Freitas, M. C. R.; Lanznaster, M.; Fernández, C. O.; Nicolás, A. R. Aroylhydrazones constitute a promising class of ‘metal-protein attenuating compounds’ for the treatment of Alzheimer’s disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazine.J. Biol. Inorg. Chem. 2018, 23, 1227-1241. [7] Amato A.; Terzo S.; Mulè F.Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease.Antioxidants 2019, 8, 608. [8] Tzikas S.; Schlak D.; Sopova K.; Gatsiou A.; Stakos D.; Stamatelopoulos K.; Stellos, K.; Laske, C. Increased Myeloperoxidase Plasma Levels in Patients with Alzheimer's Disease.J. Alzheimer's Dis. 2014, 39, 557-564. [9] Santos D. C.; Henriques R. H.; Junior M. A.A. L.; Farias, A. B.; Nogueira, T. L. C.; Quimas, J. V. F.; Romeiro, N. C.; Silva, L. A.; de Souza, A. L. F. Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer’s disease: Radical scavenging, myeloperoxidase/acetylcholin- esterase inhibition and biometal chelation.Bioorg. Med. Chem. 2020, 28, 115470. [10] da Silva, E. T.; Araújo, A. S.; Moraes, A. M.; de Souza, L. A.; Lourenço, M. C. S.; de Souza, M. V. N.; Wardell, J. L.; Wardell, S. M. S. V. Synthesis and Biological Activities of Camphor Hydrazone and Imine Derivatives.Sci. Pharm. 2016, 84, 467-483. [11] Ellman G. L.; Courtney D. K.; Andres Jr. V.; Feather-Stone, R. M. A new and rapid colorimetric determination of acetylcholin- esterase activity.Biochem. Pharmacol. 1961, 7, 88-90. [12] Kumar A.; Darreh-Shori, T. DMSO: A Mixed-Competitive Inhibitor of Human Acetylcholinesterase. ACS Chem. Neurosci.2017, 20, 2618-2625. [13] Kariya K.; Lee E.; Hirouchi M.; Hosokawa M.; Sayo H.Purification and some properties of peroxidases of rat bone marrow.Biochim. Biophys. Acta 1987, 911, 95-101. [14] Kettle A. J.; Winterbourn C. C.In Methods in Enzymology. Vol. 233, Academic Press, Cambridge, 1994, p. 502. [15] Brand-Williams W.; Cuvelier M. E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci. Technol.1995, 28, 25-30. |